AllPeptides.eu - Advanced Peptide Research
    Back to matrix
    Cellular

    MOTS-c

    None of the 30 tracked EU+ jurisdictions lists MOTS-c as authorised. This page summarises approval status, brands, shortages and recent regulatory changes by country.

    Protocol detail references

    5mg10mg20mg40mg50mg

    Related regulatory compounds

    NAD+

    Country-by-country approval and availability

    30 EU+ jurisdictions covered.

    🇩🇪
    Germany

    Participating in early metabolic clinical protocols.

    Phase II
    France

    Early research stage — not clinically available.

    Investigational
    🇮🇹
    Italy

    Early research stage — not clinically available.

    Investigational
    🇪🇸
    Spain

    Early research stage — not clinically available.

    Investigational
    🇳🇱
    Netherlands

    Participating in early metabolic clinical protocols.

    Phase II
    🇬🇷
    Greece

    Early research stage — not clinically available.

    Investigational
    🇸🇪
    Sweden

    Participating in early metabolic clinical protocols.

    Phase II
    🇩🇰
    Denmark

    Participating in early metabolic clinical protocols.

    Phase II
    🇫🇮
    Finland

    Early research stage — not clinically available.

    Investigational
    🇦🇹
    Austria

    Early research stage — not clinically available.

    Investigational
    🇧🇪
    Belgium

    Early research stage — not clinically available.

    Investigational
    🇱🇺
    Luxembourg

    Early research stage — not clinically available.

    Investigational
    🇵🇹
    Portugal

    Early research stage — not clinically available.

    Investigational
    🇮🇪
    Ireland

    Early research stage — not clinically available.

    Investigational
    🇵🇱
    Poland

    Early research stage — not clinically available.

    Investigational
    🇨🇿
    Czech Republic

    Early research stage — not clinically available.

    Investigational
    🇸🇰
    Slovakia

    Early research stage — not clinically available.

    Investigational
    🇭🇺
    Hungary

    Early research stage — not clinically available.

    Investigational
    🇸🇮
    Slovenia

    Early research stage — not clinically available.

    Investigational
    🇭🇷
    Croatia

    Early research stage — not clinically available.

    Investigational
    🇪🇪
    Estonia

    Early research stage — not clinically available.

    Investigational
    🇱🇻
    Latvia

    Early research stage — not clinically available.

    Investigational
    🇱🇹
    Lithuania

    Early research stage — not clinically available.

    Investigational
    🇷🇴
    Romania

    Early research stage — not clinically available.

    Investigational
    🇧🇬
    Bulgaria

    Early research stage — not clinically available.

    Investigational
    🇨🇾
    Cyprus

    Early research stage — not clinically available.

    Investigational
    🇲🇹
    Malta

    Early research stage — not clinically available.

    Investigational
    🇬🇧
    United Kingdom

    Participating in early metabolic clinical protocols.

    Phase II
    🇨🇭
    Switzerland

    Participating in early metabolic clinical protocols.

    Phase II
    🇳🇴
    Norway

    Early research stage — not clinically available.

    Investigational

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu

    Join on TelegramJoin on WhatsApp